Prostashield (Abiraterone Acetate 250 Mg Tablets)

Abiraterone Acetate 250 mg Tablets

Protective Shield For Prostate Cancer

• Effective Androgen Suppression
  Abiraterone Acetate’s unique mechanism of action inhibits androgen production, slowing disease progression.

• Proven Efficacy
  Clinically demonstrated to improve overall survival and delay disease progression in metastatic castration-resistant prostate cancer.

• Combination Therapy
  Used in combination with prednisone to manage side effects and enhance efficacy.

• Well Established Safety Profile
  Long term safety data supports its use in patients with advanced prostate cancer.

• Improved Quality of Life
  By slowing disease progression, Abiraterone acetate can help patients maintain their quality of life.

• Convenient Oral Dosage
  Once daily oral administration enhances patient compliance and convenience.

• Extensive Clinical Experience
  Decades of clinical use and research support its safety and effectiveness.

• Globally Recognized Treatment
  Widely accepted and recommended in clinical guidelines for metastatic castration-resistant prostate cancer.